Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$9K Hold
250
﹤0.01% 478
2020
Q1
$5K Hold
250
﹤0.01% 543
2019
Q4
$5K Hold
250
﹤0.01% 558
2019
Q3
$6K Hold
250
﹤0.01% 530
2019
Q2
$9K Hold
250
﹤0.01% 466
2019
Q1
$8K Hold
250
﹤0.01% 492
2018
Q4
$6K Sell
250
-48
-16% -$1.23K ﹤0.01% 503
2018
Q3
$9K Hold
298
﹤0.01% 499
2018
Q2
$4K Buy
+298
New +$3.42K ﹤0.01% 651

Other funds holding CDNA

TrueWealth LLC's CDNA Position: Q2 2020 in Review

TrueWealth LLC held its CareDx (CDNA) position steady in Q2 2020 at 250 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

TrueWealth LLC first reported a position in CDNA in Q2 2018 and has held it in 9 quarters since. 189 funds tracked by Wall St. Rank hold CDNA as of Q2 2020.

  • TrueWealth LLC held 250 shares of CareDx worth $9K as of Q2 2020.
  • TrueWealth LLC left its CareDx share count unchanged in Q2 2020.
  • CareDx made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #478 holding.
  • TrueWealth LLC first reported a position in CareDx in Q2 2018 and has held it in 9 quarters since.
  • 189 funds tracked by Wall St. Rank held CareDx as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.